Table 1.

Summary of subject characteristics

AGS-16M8F(Hyb)AGS-16C3F(CHO)
Enrollment and histology26 total, 19 clear, 7 nonclearDose determining: 14 total, 10 clear, 4 non–clear cell
Dose expansion: 20 total, 15 clear, 5 papillary
Gender19 male, 7 female27 male, 7 female
Median age65 (47–80)64 (46–84)
ECOG0 (10, 38.5%), 1 (15, 57.7%), 1 missing0 (11, 32.4%), 1 (23, 67.6%)
Median prior therapies3 (0–8) 24/26 (92.3% had at least 1 prior line of treatment)3 (0–7) 33/34 (97.1%) had at least 1 prior line of treatment
  • Abbreviation: ECOG, Eastern Cooperative Oncology Group.